AFC-HD AMS Life Science Co., Ltd.
2927.T · JPX
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥12,055 | ¥11,717 | ¥11,179 | ¥10,820 |
| - Cash | ¥11,200 | ¥12,172 | ¥11,182 | ¥10,378 |
| + Debt | ¥24,142 | ¥22,892 | ¥19,538 | ¥17,135 |
| Enterprise Value | ¥24,997 | ¥22,437 | ¥19,535 | ¥17,577 |
| Revenue | ¥32,655 | ¥30,185 | ¥25,579 | ¥22,997 |
| % Growth | 8.2% | 18% | 11.2% | – |
| Gross Profit | ¥10,970 | ¥10,491 | ¥9,323 | ¥8,579 |
| % Margin | 33.6% | 34.8% | 36.4% | 37.3% |
| EBITDA | ¥3,799 | ¥3,098 | ¥2,588 | ¥2,300 |
| % Margin | 11.6% | 10.3% | 10.1% | 10% |
| Net Income | ¥1,449 | ¥1,252 | ¥1,103 | ¥735 |
| % Margin | 4.4% | 4.1% | 4.3% | 3.2% |
| EPS Diluted | 102.97 | 88.96 | 78.46 | 52.08 |
| % Growth | 15.7% | 13.4% | 50.7% | – |
| Operating Cash Flow | ¥1,787 | ¥1,540 | ¥865 | ¥1,492 |
| Capital Expenditures | -¥3,539 | -¥3,407 | -¥1,940 | -¥958 |
| Free Cash Flow | -¥1,752 | -¥1,867 | -¥1,074 | ¥534 |